Clinical Trial Update: Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on active myeloid-target compound combinations for myelodysplastic syndromes with myeloproliferative neoplasm overlap (ABNL-MARRO). The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm

Snippet

Sponsor: Michael Savona | Conditions: MDS/MPN | Phase 1, Phase 2 | Status: RECRUITING